Avoid common mistakes on your manuscript.
Correction to: Cancer Immunology, Immunotherapy https://doi.org/10.1007/s00262-023-03395-6
The original version of this article unfortunately contained a mistake. The corrected details are given below for your reading.
Equal contributor statement was missing. Equal contributor statement should be "Yuhang Guo is the co-first author".
The statistical result in Fig. 2B has some mistakes.
The statistical analysis was not markered in Fig. 3A, C and F, and the statistical analysis result of Fig. 3B was misplaced.
The corrected Figs. 2 and 3 are given in the following page.
Pirb promotes GBM progression through an immunosuppressive TME. A The proliferation of GL261-LV-nc, GL261-pirb+, GL261-nc and GL261-pirb− cells detected by CCK8 assays at 24, 48 and 72 h. Statistical analysis of cell apoptosis B, migration C and invasion D in GL261-LV-nc, GL261-pirb+, GL261-nc and GL261-pirb− cells. The presence of MDSCs E, Tregs F, CD4+ and CD8+ T cells G in human GBM tissue detected by IF. *P < 0.05, ** P < 0.01, ***P < 0.001, or ****P < 0.0001, ns indicates no statistical significance
High pirb expression leads to immunosuppression. The percentages of MDSCs A, Tregs B, CD8+ T cells C and CD4+ cells D in the tumor sites detected by flow cytometry. The percentages of CD8+ T cells E, MDSCs F, CD4+ T cells G and Treg cells H in the spleens of tumor-bearing mice detected by flow cytometry. *P < 0.05, ** P < 0.01, ***P < 0.001, or ****P < 0.0001, ns indicates no statistical significance
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wu, P., Guo, Y., Xiao, L. et al. Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells. Cancer Immunol Immunother 72, 2195–2196 (2023). https://doi.org/10.1007/s00262-023-03426-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-023-03426-2